Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study (Q42869103)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2010
edit
Language Label Description Also known as
English
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study
scientific article published on October 2010

    Statements

    Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study (English)
    Srinivas R Sadda
    Glenn Stoller
    David S Boyer
    Barbara A Blodi
    Howard Shapiro
    Tsontcho Ianchulev
    1 October 2010
    1390-1399

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit